单一治疗高血压患者的血压反应和控制率:四种不同的抗高血压药物类别的随机比较
Kidney & blood pressure research
|April 21, 2025
概括
初始的抗高血压单一治疗中,使用西,奥尔梅沙坦,阿姆洛迪平或基胺的疗效不同. 列宁- ангиотензин- алдостерон系统抑制剂与甲相比显示出更好的血压控制,支持组合疗法.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 高血压管理 高血压管理
背景情况:
- 以前的指导方针建议四个类别的抗高血压药物同等用于初始治疗.
- 这些药物类别在实现血压控制方面的比较疗效尚不清楚.
- 这项研究旨在比较四种一线抗高血压药物类别的应答率和血压控制.
研究的目的:
- 为了比较二多普里尔,奥尔梅沙坦,阿姆洛迪平和基在实现血压控制方面的疗效.
- 评估新诊断高血压患者的应答率和血压降低.
主要方法:
- 在88名轻度至中度高血压患者的随机试验中,使用24小时的门诊血压监测 (ABPM).
- 患者被分配给佩林多普里尔,奥尔梅沙坦,阿姆洛迪平或酸 (HCT).
- 根据4周和8周的ABPM读数进行了剂量调整,以评估血压控制.
主要成果:
- 奥尔梅沙坦显示了最大的血压降低 (-15/-10 mm Hg),而HCT显示了最低的 (-8/-1 mm Hg).
- 只有27%的患者实现了静脉-透气血压控制;印布里尔和奥尔梅沙坦的控制率最高 (40%和39%).
- 甲证明了血压控制率最低的 (5%).
结论:
- 最初的抗高血压单一治疗对大多数患者来说不足,药物类别之间的疗效有显著差异.
- 氨酸- ангиотензин- алдостерон系统的抑制剂 (氨酸,奥尔梅沙坦) 比氨酸更有效.
- 这些发现支持了在高血压管理中联合治疗的指导方针建议.
相关概念视频
01:16Antihypertensive Drugs: Action of Diuretics
572
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
572
01:23Antihypertensive Drugs: Vasodilators
426
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
426
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
530
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
530
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
01:25Antihypertensive Drugs: Direct Renin Inhibitors
440
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
440
01:28Antihypertensive Drugs: Types of β-Blockers
511
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
511